Last update Jan. 28, 2025

Colistin Sulfate (Polymyxin E)

Compatible

Safe product and/or breastfeeding is the best option.

Colistin is a polymyxin antibacterial. It is used intramuscularly or intravenously in the treatment of severe gram-negative infections, in cystic fibrosis by inhalation and orally for decontamination of the digestive tract in preparation for surgery. (Coria 2011, Luque 2011)

Its pharmacokinetic data (high volume of distribution and molecular weight) would explain the small passage into milk observed in two old publications after intramuscular administration. (Borderon 1975 and Moiraghi 1964, cited in LactMed-colistimethate).

The lack of oral bioavailability suggests little or no passage into infant plasma from ingested breast milk, except in premature infants and the immediate neonatal period, where there may be increased intestinal absorption.

Intravenous use authorised in Paediatrics and Neonatology.

Inhaled use is also compatible with breastfeeding. (Middleton 2020)

Alternatives

  • Amikacin (Safe product and/or breastfeeding is the best option.)
  • Gentamicin Sulfate (Safe product and/or breastfeeding is the best option.)
  • Imipenem + Cilastatin (Safe product and/or breastfeeding is the best option.)
  • Tobramycin (Safe product and/or breastfeeding is the best option.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Colistin Sulfate (Polymyxin E) is also known as


Colistin Sulfate (Polymyxin E) in other languages or writings:

Tradenames

Main tradenames from several countries containing Colistin Sulfate (Polymyxin E) in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. ≈ 0 %
Molecular weight 1.750 daltons
Protein Binding 50 %
VD 0.34 ± 0.1 l/Kg
Tmax 1 - 7 hours
2 ± 0.9 hours
M/P ratio 0.2 -
Theoretical Dose 0.03 - 0.12 mg/Kg/d
Relative Dose 2.7 - 10 %
Ped.Relat.Dose < 3 %

References

  1. LactMed. Drugs and Lactation Database (LactMed). Internet. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/ 2006 - Consulted on April 16, 2024 Full text (link to original source)
  2. Middleton PG, Gade EJ, Aguilera C, MacKillop L, Button BM, Coleman C, Johnson B, Albrechtsen C, Edenborough F, Rigau D, Gibson PG, Backer V. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J. 2020 Feb 6;55(2). pii: 1901208. Abstract Full text (link to original source) Full text (in our servers)
  3. José de Jesús Coria Lorenzo, Alfredo Morayta Ramírez, Yetzamin Gutiérrez Muñoz. Polimixinas en la era de la multidrogorresistencia. Revista de Enfermedades Infecciosas en Pediatría 2011;25(98):66-70. 2011 Full text (in our servers)
  4. Luque S, Grau S, Berenguer N, Horcajada JP, Sorlí L, Montero MM, Salas E. Luces y sombras en el uso de colistina: falta mucho por conocer. [Shedding light on the use of colistin: still gaps to be filled]. Enferm Infecc Microbiol Clin. 2011 Abstract Full text (link to original source)
  5. Ratjen F, Rietschel E, Kasel D, Schwiertz R, Starke K, Beier H, van Koningsbruggen S, Grasemann H. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. J Antimicrob Chemother. 2006 Abstract
  6. Li J, Coulthard K, Milne R, Nation RL, Conway S, Peckham D, Etherington C, Turnidge J. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J Antimicrob Chemother. 2003 Abstract

Total visits

7,747

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM